Sep. 3 at 9:13 PM
$CRIS They need to negotiate some kind of royalty deal with one of their partners. It may not get them a ton of money, but it should get them over that 35M threshhold. To not do this is sheer incompetence on the part of mgmt. They cannot borrow at any reasonable price, and their stock sales are a horror show. They will go bk if they do not stay listed. Some opportunist will buy the assets and finish the testing.
Anybody here wanna join me in putting together a bid? (Minimum 1M investment each, we don't want a jillion partners.) If we finish the trials, there is good chance we can deal with some of the biotech partners. First order of biz, get rid of the current mgmt team.
